BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Martins JP, Figueiredo P, Wang S, Espo E, Celi E, Martins B, Kemell M, Moslova K, Mäkilä E, Salonen J, Kostiainen MA, Celia C, Cerullo V, Viitala T, Sarmento B, Hirvonen J, Santos HA. Neonatal Fc receptor-targeted lignin-encapsulated porous silicon nanoparticles for enhanced cellular interactions and insulin permeation across the intestinal epithelium. Bioact Mater 2022;9:299-315. [PMID: 34820572 DOI: 10.1016/j.bioactmat.2021.08.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Li M, Zhang W, Li J, Qi Y, Peng C, Wang N, Fan H, Li Y. Zwitterionic polymers: addressing the barriers for drug delivery. Chinese Chemical Letters 2023. [DOI: 10.1016/j.cclet.2023.108177] [Reference Citation Analysis]
2 Hameedat F, Pinto S, Marques J, Dias S, Sarmento B. Functionalized zein nanoparticles targeting neonatal Fc receptor to enhance lung absorption of peptides. Drug Deliv Transl Res 2023. [PMID: 36587110 DOI: 10.1007/s13346-022-01286-4] [Reference Citation Analysis]
3 Liu W, Ma R, Lu S, Wen Y, Li H, Wang J, Sun B. Acid-Resistant Mesoporous Metal-Organic Frameworks as Carriers for Targeted Hypoglycemic Peptide Delivery: Peptide Encapsulation, Release, and Bioactivity. ACS Appl Mater Interfaces 2022;14:55447-57. [PMID: 36478454 DOI: 10.1021/acsami.2c18452] [Reference Citation Analysis]
4 Zhang Y, Wang Y, Li X, Nie D, Liu C, Gan Y. Ligand-modified nanocarriers for oral drug delivery: Challenges, rational design, and applications. J Control Release 2022;352:813-32. [PMID: 36368493 DOI: 10.1016/j.jconrel.2022.11.010] [Reference Citation Analysis]
5 Li X, Fang S, Yu Y, Yang H, Rao Y, Hong D, Lu C, Yu M, Lu X, Yu C, Zhao Q. Oral administration of inflammatory microenvironment-responsive carrier-free infliximab nanocomplex for the targeted treatment of inflammatory bowel disease. Chemical Engineering Journal 2022;445:136438. [DOI: 10.1016/j.cej.2022.136438] [Reference Citation Analysis]
6 Hameedat F, Pizarroso NA, Teixeira N, Pinto S, Sarmento B. Functionalized FcRn-targeted nanosystems for oral drug delivery: A new approach to colorectal cancer treatment. Eur J Pharm Sci 2022;176:106259. [PMID: 35842140 DOI: 10.1016/j.ejps.2022.106259] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 De Marchi JGB, Cé R, Onzi G, Alves ACS, Santarém N, Cordeiro da Silva A, Pohlmann AR, Guterres SS, Ribeiro AJ. IgG functionalized polymeric nanoparticles for oral insulin administration. Int J Pharm 2022;:121829. [PMID: 35580686 DOI: 10.1016/j.ijpharm.2022.121829] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Vitulo M, Gnodi E, Meneveri R, Barisani D. Interactions between Nanoparticles and Intestine. IJMS 2022;23:4339. [DOI: 10.3390/ijms23084339] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Li Y, Zhang W, Zhao R, Zhang X. Advances in oral peptide drug nanoparticles for diabetes mellitus treatment. Bioact Mater 2022;15:392-408. [PMID: 35386357 DOI: 10.1016/j.bioactmat.2022.02.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]